European experts recommend multigene testing to help breast cancer treatment decisions
This article was originally published in Clinica
Executive Summary
For the first time, a European body of experts has recommended that validated multigene assays should be considered a useful add-on to conventional methods for determining which early-stage breast cancer patients will benefit from chemotherapy.